Age Related Macular
Degeneration (AMD) is a common eye disorder and basic reason of vision loss
after 50. Macula is a minor spot close to the midpoint of the retina and an
important part of the eye required for sharp, central vision; which helps us to
see the substances that are straight ahead. The growing age causes damage to
the macula.
The Macula is formed from
millions of light detecting cells that deliver sharp, central vision. It is the
utmost sensitive part of the retina. It is placed at the rear portion of the
eye. The retina converts light into electrical signals and then directs these
electrical signals through the optic nerve to the brain. Here they are decoded
into the pictures we understand. Once the macula is injured, the center of your
field of vision may look blurry, slanted, or black.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/age-related-macular-degeneration-amd-market
By type, the worldwide AMD
market is segmented into Dry (AMD is due to the formation of the deposits
called ‘’Drusen’’, under the retina.) and Wet (AMD is due to irregular growth
of the blood vessels from the choroid beneath the macula). Most of the patients
form dry AMD, but it may later lead to wet form of AMD. Growing age is the main
risk factor. Persons above 60 are the main victims.
However, it may arise before
as well. Growing geriatric population worldwide is the prime driving factor for
AMD market. Besides, the sedentary lifestyle coupled with increasing
consumption of pipeline drugs for AMD is also driving the market. However, the
factors restraining the growth of global AMD market are stringent regulations
on the part of governments and the ever-increasing off label usage.
Worldwide Market segmentation
by geography includes North America, Asia Pacific, Europe, and Rest of the
world. North America leads the market. This lead could be attributed to the
increasing number of AMD-positive Americans every year. This trend is expected
to continue in the forecast period (2014-2025). The major players worldwide are
Bayer Healthcare (a subsidiary of Bayer AG), Novartis AG, Genentech Inc. (a
Roche Group member), Regeneron Pharmaceuticals, Pfizer Inc., Valent
Pharmaceuticals International.
Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/age-related-macular-degeneration-amd-market/request-sample
No comments:
Post a Comment